As a leader in pharmacogenomics (PGx), Admera Health offers the most comprehensive clinical PGx test in the industry, covering 62 genes, 270+ medications, and over 20 therapeutic areas. September 28, 2021 SOUTH PLAINFIELD, N.J.--(BUSINESS WIRE)--Admera Health, a precision-medicine company and genetics laboratory, announced today that it has engaged Back [...]

May 26, 2020 SAN FRANCISCO, California and SOUTH PLAINFIELD, New Jersey, May 26, 2020 – Hygea Precision Medicine (Hygea), a company focused on developing a precision medicine software system for healthcare providers and patients to effectively manage genomic testing, and Admera Health, a premier precision medicine company and genetics [...]

Admera Health Medical Director, Ruben Bonilla-Guerrero, MD, FACMG, FAACC, Awarded Annals of Translational Medicine Outstanding Author 2019 Dr. Ruben Bonilla-Guerrero was recently awarded 2019 Outstanding Author, in recognition of his great contribution entitled, "Laboratory diagnostic approaches in metabolic disorders" to Annals of Translational Medicine (Print ISSN 2305-5839; Online ISSN [...]

Admera Health Medical Director, Ruben Bonilla-Guerrero, MD, FACMG, FAACC, to Present at Precision Medicine World Conference 2020 Dr. Ruben Bonilla-Guerrero will present in the PMWC 2020 Clinical Diagnostics Showcase for selected organizations, to exhibit their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic [...]

Admera Health Announces Appointment of Omar Karame as Chief Financial Officer December 10, 2019 11:45 ET SOUTH PLAINFIELD, N.J., Dec. 10, 2019 (GLOBE NEWSWIRE) -- Admera Health, a molecular diagnostics company, welcomes Omar Karame as Chief Financial Officer to the company. Mr. Karame brings to Admera Health more than [...]